Target intelligence / Profile preview

Solute carrier family 19 member 1 (SLC19A1)

Target
SLC19A1
Molecular classification
Transporter, Solute carrier family, Organic anion transporter
01

Overview

Solute carrier family 19 member 1 (SLC19A1), commonly known as the Reduced Folate Carrier (RFC), is the primary protein responsible for the transport of reduced folates from the extracellular environment into the cytoplasm. It functions as an organic anion antiporter, exchanging intracellular organic phosphates for extracellular folates, and is ubiquitously expressed in mammalian tissues to maintain one-carbon metabolism (UniProt P41440). In addition to its role in nutrient uptake, SLC19A1 is the major gateway for several clinically important antifolate chemotherapeutics, including methotrexate and pemetrexed (PubMed: 24552113). Recent research has also identified SLC19A1 as a key transporter for cyclic dinucleotides like cGAMP, which are critical for activating the STING-mediated innate immune response (PubMed: 31511694). Alterations in SLC19A1 expression or function are frequently associated with methotrexate resistance in cancer treatment and have been linked to developmental defects such as neural tube defects due to impaired folate transport during embryogenesis (PubMed: 11844478).

Other names
Reduced folate carrier 1RFC1Folate transporter 1Intestinal folate carrier 1IFC-1Placental folate transporter
02

Mechanism of action

Acts as a bidirectional facilitative transporter that mediates the uptake of reduced folates and antifolate drugs into cells via an organic anion exchange mechanism.

03

Biological functions

Folate homeostasisTransmembrane transportOne-carbon metabolismCyclic dinucleotide transportImmune signaling
04

Disease associations

CancerFolate deficiencyNeural tube defectsMethotrexate resistanceAutoimmune disease
05

Safety considerations

Drug resistance due to transporter downregulationSystemic toxicity of antifolates in high-expressing normal tissuesCompetition between dietary folates and antifolate drugsGenetic polymorphisms affecting drug pharmacokinetics
06

Interacting drugs

Methotrexate

6 more in the full profile.

07

Biomarkers

SLC19A1 mRNA expression levelsSLC19A1 G80A polymorphismRFC1 protein expression (IHC)

Beyond the preview

Go deeper on Solute carrier family 19 member 1 (SLC19A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 19 member 1 (SLC19A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call